2016 Molecular Diagnostics Coding and Billing: Strategies for Getting Your Claims Paid

2016 Molecular Diagnostics Coding and Billing: Strategies for Getting Your Claims Paid

With an average of 41% of molecular diagnostic (MDx) test claims being denied by Medicare Part B contractors, it’s critical that clinical laboratories use the correct codes and know when and how to appeal when claims are denied.

Please join Laboratory Economics and host Kimberly Scott for a 75-minute conference call where two industry experts, Charles Root with CodeMap, and Rina Wolf with XIFIN Inc., will provide an update on the latest in MDx coding and billing for 2016.

Featured XIFIN Speaker

Rina Wolf
Vice President, Commercialization Strategies, Consulting & Industry Affairs
XIFIN, Inc.
 

Laboratory Economics is the brainchild of Jondavid Klipp, a nationally recognized expert on the business of laboratory medicine. His research has appeared in numerous business and trade publications including the Wall Street Journal, New York Times and Medical Laboratory Observer.

Details

Laboratory Economics
EVENT TYPE:
Webinar
WHEN:
May 5, 2016
EVENT WEBSITE:
www.laboratoryeconomics.com
XIFIN SPEAKER(S):

Rina Wolf, Vice President, Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc.

SPEAKER(S):

Charles Root, CEO, CodeMap

MODERATOR:

Kimberly Scott, former Managing Editor, G2 Intelligence